WP
Woodline Partners Portfolio holdings
AUM
$18.9B
1-Year Return
23.37%
This Quarter Return
+13.42%
1 Year Return
+23.37%
3 Year Return
+125.78%
5 Year Return
+185.63%
10 Year Return
–
AUM
$10.8B
AUM Growth
+$1.65B
(+18%)
Cap. Flow
+$863M
Cap. Flow
% of AUM
7.98%
Top 10 Holdings %
Top 10 Hldgs %
14.33%
Holding
675
New
211
Increased
170
Reduced
126
Closed
150
Top Buys
| 1 |
ERF
Enerplus Corporation
ERF
|
$110M |
| 2 |
TE Connectivity
TEL
|
$84.6M |
| 3 |
Arthur J. Gallagher & Co
AJG
|
$78.6M |
| 4 |
Honeywell
HON
|
$72.8M |
| 5 |
Palo Alto Networks
PANW
|
$71.1M |
Top Sells
| 1 |
AbbVie
ABBV
|
$116M |
| 2 |
KRTX
Karuna Therapeutics, Inc. Common Stock
KRTX
|
$113M |
| 3 |
INBX
Inhibrx, Inc. Common Stock
INBX
|
$88.1M |
| 4 |
Permian Resources
PR
|
$75M |
| 5 |
SPLK
Splunk Inc
SPLK
|
$70.1M |
Sector Composition
| 1 | Healthcare | 38.65% |
| 2 | Technology | 22.91% |
| 3 | Industrials | 9.85% |
| 4 | Energy | 8.37% |
| 5 | Consumer Discretionary | 7.34% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
351
ScottsMiracle-Gro
SMG
$3.64B
| $5.21M | 0.05% |
+69,813
| New | +$5.21M |
|
352
Krispy Kreme
DNUT
$579M
| $5.18M | 0.05% |
339,873
+250,936
| +282% | +$3.82M |
|
|
SLN
353
Silence Therapeutics
SLN
$269M
| $5.15M | 0.05% |
238,380
+189,108
| +384% | +$4.08M |
|
354
TriNet
TNET
$3.43B
| $5.13M | 0.05% |
+38,704
| New | +$5.13M |
|
355
NVIDIA
NVDA
$4.07T
| $5.12M | 0.05% |
56,660
-311,360
| -85% | -$28.1M |
|
356
RingCentral
RNG
$2.89B
| $5.1M | 0.05% |
146,792
-12,638
| -8% | -$439K |
|
357
BioNTech
BNTX
$27B
| $5.05M | 0.05% |
54,735
-72,825
| -57% | -$6.72M |
|
358
Nuvalent
NUVL
$5.83B
| $4.92M | 0.05% |
65,492
| – | – |
|
359
Telephone and Data Systems
TDS
$4.54B
| $4.88M | 0.04% |
304,527
+33,527
| +12% | +$537K |
|
360
Endava
DAVA
$553M
| $4.87M | 0.04% |
127,931
| – | – |
|
361
Fortrea Holdings
FTRE
$1.06B
| $4.85M | 0.04% |
120,925
-65,186
| -35% | -$2.62M |
|
362
Astera Labs
ALAB
$31.8B
| $4.82M | 0.04% |
+64,945
| New | +$4.82M |
|
363
Bilibili
BILI
$9.25B
| $4.71M | 0.04% |
+420,246
| New | +$4.71M |
|
364
Knowles
KN
$1.85B
| $4.7M | 0.04% |
+291,755
| New | +$4.7M |
|
365
Cogent Biosciences
COGT
$1.82B
| $4.69M | 0.04% |
698,378
-92,106
| -12% | -$619K |
|
366
Soleno Therapeutics
SLNO
$3.71B
| $4.56M | 0.04% |
106,460
-93,540
| -47% | -$4M |
|
367
Charles River Laboratories
CRL
$8.07B
| $4.55M | 0.04% |
+16,780
| New | +$4.55M |
|
368
Day One Biopharmaceuticals
DAWN
$773M
| $4.5M | 0.04% |
272,538
| – | – |
|
369
TopBuild
BLD
$12.3B
| $4.42M | 0.04% |
10,038
+4,168
| +71% | +$1.84M |
|
370
Astrana Health
ASTH
$1.37B
| $4.37M | 0.04% |
+103,975
| New | +$4.37M |
|
371
Bausch Health
BHC
$2.72B
| $4.34M | 0.04% |
+409,333
| New | +$4.34M |
|
372
Synopsys
SNPS
$111B
| $4.25M | 0.04% |
7,441
-117,326
| -94% | -$67.1M |
|
373
Jackson Financial
JXN
$6.65B
| $4.22M | 0.04% |
+63,849
| New | +$4.22M |
|
374
Lyra Therapeutics
LYRA
$11.3M
| $4.21M | 0.04% |
13,531
+1,531
| +13% | +$476K |
|
375
Amneal Pharmaceuticals
AMRX
$3.02B
| $4.17M | 0.04% |
+688,106
| New | +$4.17M |
|